drugset / Trial / NCT03505255
Comparison Between Intraperitoneal Versus Intramuscular Neostigmine on Pattern of Postoperative GIT Motility in Patients Undergoing Laparoscopic Cholecystectomy
RandomizedParallel-groupDouble-blindTreatment
Summary
The goal in this work is to compare between the effects of intraperitoneal versus intramuscular neostigmine on pattern of postoperative GIT motility in patients undergoing laparoscopic cholecystectomy
Timeline
- Start
- 2018-09-01
- Primary completion
- 2020-09
- Completion
- 2020-10
Publications
- Background Baig MK, Wexner SD. Postoperative ileus: a review. Dis Colon Rectum. 2004 Apr;47(4):516-26. doi: 10.1007/s10350-003-0067-9. Epub 2004 Feb 25.
- Background Delaney CP, Wolff BG, Viscusi ER, Senagore AJ, Fort JG, Du W, Techner L, Wallin B. Alvimopan, for postoperative ileus following bowel resection: a pooled analysis of phase III studies. Ann Surg. 2007 Mar;245(3):355-63. doi: 10.1097/01.sla.0000232538.72458.93.
- Background Schuster R, Grewal N, Greaney GC, Waxman K. Gum chewing reduces ileus after elective open sigmoid colectomy. Arch Surg. 2006 Feb;141(2):174-6. doi: 10.1001/archsurg.141.2.174.
- Background Sajja SB, Schein M. Early postoperative small bowel obstruction. Br J Surg. 2004 Jun;91(6):683-91. doi: 10.1002/bjs.4589.
- Background Viscusi ER, Goldstein S, Witkowski T, Andonakakis A, Jan R, Gabriel K, Du W, Techner L, Wallin B. Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study. Surg Endosc. 2006 Jan;20(1):64-70. doi: 10.1007/s00464-005-0104-y. Epub 2005 Dec 7.
- Background Husebye E. Gastrointestinal motility disorders and bacterial overgrowth. J Intern Med. 1995 Apr;237(4):419-27. doi: 10.1111/j.1365-2796.1995.tb01196.x.
- Background Holte K, Kehlet H. Postoperative ileus: a preventable event. Br J Surg. 2000 Nov;87(11):1480-93. doi: 10.1046/j.1365-2168.2000.01595.x.
- Background Goyal RK, Hirano I. The enteric nervous system. N Engl J Med. 1996 Apr 25;334(17):1106-15. doi: 10.1056/NEJM199604253341707. No abstract available.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Neostigmine | Other / unclassified | 0.25 mg | Intrathecal |
| Comparator | Neostigmine | Other / unclassified | 0.5 mg | Intrathecal |
Indications
No indication recorded.